Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
06/2002
06/06/2002WO2002044384A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
06/06/2002WO2002044380A2 Master bone formation transcription factor: compositions and methods of use
06/06/2002WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof
06/06/2002WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
06/06/2002WO2002044347A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it
06/06/2002WO2002044346A2 Stem cells, method for expansion in vitro and use thereof
06/06/2002WO2002044345A1 Methods and products for manipulating hematopoietic stem cells
06/06/2002WO2002044343A2 Tolerizing allografts of pluripotent stem cells
06/06/2002WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/06/2002WO2002044322A2 Bacteriophage composition useful in treating food products to prevent bacterial contamination
06/06/2002WO2002043740A1 Method for producing an immunotropic antiviral preparation
06/06/2002WO2002043651A2 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
06/06/2002WO2002043649A2 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
06/06/2002WO2002043647A2 Oncolytic virus
06/06/2002WO2002043570A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
06/06/2002WO2002043485A1 Storage solution containing photosensitizer for inactivation of biological contaminants
06/06/2002WO2002024001A3 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
06/06/2002WO2002000906A3 Replication deficient adenoviral tnf vector
06/06/2002WO2001094549A3 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway
06/06/2002WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
06/06/2002WO2001083716A3 Immortalized lines of endothelial brain cells and therapeutic application thereof
06/06/2002WO2001079442A3 Albumin fusion proteins
06/06/2002WO2001077300A3 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
06/06/2002WO2000022430A3 Neisseria genomic sequences and methods of their use
06/06/2002US20020068893 Method for preparing leucocyte-free blood preparation and blood administration set
06/06/2002US20020068825 Polypeptide for use in the treatment of nervous system disorders
06/06/2002US20020068713 Genetic engineering of vascular grafts to resist disease
06/06/2002US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells
06/06/2002US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein
06/06/2002US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer
06/06/2002US20020068071 Enhancement of the cellular immune response
06/06/2002US20020068053 Process for the production of anti-tumor Th1 cells
06/06/2002US20020068051 Generation and use of signal-plexes to develop specific cell types, tissues and /or organs
06/06/2002US20020068048 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
06/06/2002US20020068046 Use of stem cells derived from dermal skin
06/06/2002US20020068045 Such as neural progenitor cells capable of giving rise to mature somatic cells including neural cells and/or glial cells recognizable by expression of specific markers
06/06/2002US20020068044 Natural killer cell lines and methods of use
06/06/2002CA2430745A1 Master bone formation transcription factor: compositions and methods of use
06/06/2002CA2430625A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it
06/06/2002CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
06/06/2002CA2430495A1 Oncolytic virus
06/06/2002CA2430341A1 Genetically engineered herpes virus for the treatment of cardiovascular disease
06/06/2002CA2430334A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol
06/06/2002CA2430292A1 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
06/06/2002CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof
06/06/2002CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol
06/06/2002CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
06/06/2002CA2429987A1 Methods for the prevention and treatment of cancer using anti-c3b(i) antibodies
06/06/2002CA2429673A1 Bacteriophage composition useful in treating food products to prevent bacterial contamination
06/06/2002CA2427996A1 Tolerizing allografts of pluripotent stem cells
06/06/2002CA2397862A1 Storage solution containing photosensitizer for inactivation of biological contaminants
06/05/2002EP1211319A2 Gene transfer into pancreatic and biliary epithelial cells
06/05/2002EP1211311A2 Cord blood-derived activated lymphocytes and preparations containing said lymphocytes
06/05/2002EP1211261A2 Stable polymerized hemoglobin blood-substitute
06/05/2002EP1210944A1 Blood plasma replacement solution
06/05/2002EP1210465A2 A method for producing quality assured biological sample and composition containing the same
06/05/2002EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
06/05/2002EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
06/05/2002EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6
06/05/2002EP1210453A2 Hdac4 and hdac5 in the regulation of cardiac gene expression
06/05/2002EP1210448A1 Recombinant hsv-1 and live viral vaccines
06/05/2002EP1210447A2 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules
06/05/2002EP1210445A2 Recombinant microorganisms
06/05/2002EP1210439A1 Coxsackie virus-derived vector system for gene transfer
06/05/2002EP1210430A2 Muc-1 derived peptides
06/05/2002EP1210422A2 Human abc2 transporter and uses thereof
06/05/2002EP1210421A1 Methods for diagnosis and treatment of human diseases including hypertension
06/05/2002EP1210420A1 Cd154 ligand, and recombinant cells expressing it
06/05/2002EP1210405A2 Cardiomyocytes with enhanced proliferative potential, and methods for preparing and using same
06/05/2002EP1210346A2 New active marine alkaloids
06/05/2002EP1210106A2 Methods, compositions and kits for promoting recovery from damage to the central nervous system
06/05/2002EP1210092A1 Calcium-containing structures and methods of making and using the same
06/05/2002EP1124593B1 Method for preparing bone material
06/05/2002EP1109817B1 Phosphohalohydrins, method for making same and uses
06/05/2002EP1009376B1 Cosmetic or dermo-phamaceutical products compatible with cutaneous ecology
06/05/2002EP0889729B1 Linseed drug
06/05/2002EP0819007B1 Urinary bladder submucosa derived tissue graft
06/05/2002EP0808167B1 Bone graft composition
06/05/2002EP0752870B1 Use of mycobacterium for the treatment of tumours
06/05/2002EP0700299B1 Oxygen-reduced aqueous solution of factor viii
06/05/2002EP0663951B1 Chitosan matrices for encapsulated cells
06/05/2002CN1352696A Adipose-derived stem cell and Lattices
06/05/2002CN1352694A Novel system for regulating transgene expression
06/05/2002CN1352683A Compositions and methods for the treatment and diagnosis of breast cancer
06/05/2002CN1351887A Externally applied Chinese medicine decoction
06/05/2002CN1351886A Chinese medicine formula for hepatic disease
06/05/2002CN1351884A Medicine for treating hepatitis B
06/05/2002CN1351880A Pus drawing out paste for expelling wind and removing obstruction in channels and its preparing method
06/05/2002CN1351869A Method for preparing nanometer level pearli powder
06/05/2002CN1085948C Process for preparing medicine to cure viral hepatitis
06/05/2002CA2327631A1 Inflammatory cytokine secretion inhibition
06/05/2002CA2327630A1 Transforming growth factor regulation
06/05/2002CA2327628A1 Deprotection of malignant cells
06/04/2002US6399826 Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
06/04/2002US6399588 Cancer treatment method utilizing plasmids suitable for IL-2 expression
06/04/2002US6399576 Administering dosage of batroxobin
06/04/2002US6399385 Conjugating a genetically engineered virus with polyethylene glycol at ambient temperature for improved gene expression
06/04/2002US6399384 Conditional immortalization of cells
06/04/2002US6399381 Mixture of inorganic salts, amino acids, amine, vitamin c, dexamethasone, calcium salt, retinoic acid, triiodothyronine, hydrocortisone, pituitary gland extract, transferrins and epidermal growth factor
06/04/2002US6399372 Monocyte derived cells with immunostimulating properties, their preparation and uses
1 ... 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 ... 1259